Diagnostic technology is enabling modern healthcare institutions provide better and safe healthcare to their patients. Horiba Medical India completely understands the need of healthcare market in terms of laboratory technology and provides state-of-the-art bespoke solutions for hematology testing laboratories since last 11 years, creating an image of a competitive brand in Indian hematology market.
However, after serving the hematology market now, Horiba Medical further created an indelible mark in the history of Indian IVD market by launching its state-of-the-art high-end hematology analyzer and clinical chemistry analyzer recently.
In a vast and diverse Indian IVD market, run-of-the-mill hematology analyzers categorized as 3-part and 5-part are abundantly available with insignificant technical modifications and aesthetic amendments.
However, currently high-end, high-throughput technology is the need of the market and has promising potential in large medical laboratories of India. Horiba Medical introduced first of its kind track system i.e. Helo solution for Indian hematology market which is an innovative design solution covering all needs of high throughout automated hematology platforms. Along with the Helo solution, Horiba Medical India also announced its entry into clinical chemistry instrument market and launched its Pentra C400 in India during one of the major Lab Expo at Pathcon 2017 held on December 17, 2017 in Delhi.
An overwhelming response was shown by pathologists. Detailed discussion ensued post-launch by the product management team where they explained the product features and strengths compared to existing potential competitors in the Indian market. This launch is a promising initiative, by Horiba Medical India, and has potential to revolutionize the Indian IVD market considering the current trends and extrapolated market statistics in India. Horiba Medical is driving this incredible pace of growth which would be even more attractive in the coming years under the strong leadership of Dr Rajeev Gautam. Horiba Medical India is poised well not just to ride the growth wave but to lead it successfully and retain its ne plus ultra.